Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | JNJ | PFE | MRK | NVS |
| Company | Novo Nordisk A/S ADR | Johnson & Johnson | Pfizer Inc | Merck & Company | Novartis Ag ADR |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 124.95 | 145.00 | 25.69 | 125.67 | 93.63 |
| High | 125.21 | 145.41 | 25.69 | 126.19 | 93.78 |
| Low | 123.26 | 143.54 | 25.26 | 124.71 | 92.87 |
| Last | 124.53 | 144.77 | 25.42 | 125.37 | 93.08 |
| Change | +1.08 | +0.32 | -0.27 | +0.31 | -0.12 |
| % Change | +0.87% | +0.22% | -1.05% | +0.25% | -0.13% |
| Volume | 3,075,100 | 9,378,000 | 43,828,797 | 6,122,900 | 1,168,700 |
| 20-Day Average Volume | 3,668,080 | 7,272,865 | 35,652,273 | 7,405,885 | 1,652,700 |
| Previous Close | 123.45 | 144.45 | 25.69 | 125.06 | 93.20 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 126.69 | 152.79 | 26.90 | 127.06 | 95.18 |
| 20-Day Raw Stochastic | 28.42% | 8.76% | 5.59% | 39.23% | 7.91% |
| 20-Day Relative Strength | 49.05% | 26.25% | 32.83% | 49.72% | 36.30% |
| Weighted Alpha | +49.17 | -13.43 | -36.79 | +13.36 | -9.52 |
| Today's Opinion | 56% Buy | 88% Sell | 100% Sell | 72% Buy | 88% Sell |
| Previous Opinion | 56% Buy | 88% Sell | 100% Sell | 72% Buy | 88% Sell |
| Last Month's Opinion | 100% Buy | 8% Buy | 56% Sell | 56% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.32% since 04/10/24 | -3.62% since 04/10/24 | -3.42% since 04/10/24 | -1.09% since 04/10/24 | -1.38% since 04/10/24 |
| Low | 121.79 on 04/16/24 | 143.39 on 04/16/24 | 25.26 on 04/17/24 | 124.71 on 04/17/24 | 92.64 on 04/16/24 |
| High | 127.06 on 04/12/24 | 150.87 on 04/11/24 | 26.45 on 04/11/24 | 127.82 on 04/15/24 | 95.05 on 04/12/24 |
| 1-Month | |||||
| %Chg | -5.92% since 03/15/24 | -8.48% since 03/15/24 | -9.02% since 03/15/24 | +3.17% since 03/15/24 | -4.31% since 03/15/24 |
| Low | 121.79 on 04/16/24 | 143.39 on 04/16/24 | 25.26 on 04/17/24 | 120.38 on 03/20/24 | 92.64 on 04/16/24 |
| High | 133.75 on 03/18/24 | 159.14 on 03/28/24 | 28.12 on 03/28/24 | 133.10 on 03/27/24 | 98.21 on 04/04/24 |
| 3-Month | |||||
| %Chg | +16.73% since 01/17/24 | -9.76% since 01/17/24 | -9.70% since 01/17/24 | +6.13% since 01/17/24 | -14.02% since 01/17/24 |
| Low | 103.38 on 01/23/24 | 143.39 on 04/16/24 | 25.26 on 04/17/24 | 116.62 on 01/18/24 | 92.64 on 04/16/24 |
| High | 138.28 on 03/07/24 | 163.58 on 01/22/24 | 28.77 on 01/24/24 | 133.10 on 03/27/24 | 108.78 on 01/22/24 |
| 6-Month | |||||
| %Chg | +23.10% since 10/17/23 | -7.25% since 10/17/23 | -22.38% since 10/17/23 | +20.35% since 10/17/23 | -3.53% since 10/17/23 |
| Low | 92.94 on 10/27/23 | 143.39 on 04/16/24 | 25.26 on 04/17/24 | 99.14 on 10/19/23 | 92.19 on 10/27/23 |
| High | 138.28 on 03/07/24 | 163.58 on 01/22/24 | 32.68 on 10/18/23 | 133.10 on 03/27/24 | 108.78 on 01/22/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 553,985,856 | 348,093,152 | 145,470,704 | 316,780,480 | 197,546,720 |
| Shares Outstanding, K | 4,487,532 | 2,409,783 | 5,662,542 | 2,533,028 | 2,119,600 |
| Annual Sales | 33,724,300,000 | 85,159,000,000 | 58,496,000,000 | 60,115,000,000 | 46,660,000,000 |
| Annual Net Income | 12,150,770,000 | 35,153,000,000 | 2,119,000,000 | 365,000,000 | 14,850,000,000 |
| Last Quarter Sales | 9,526,160,000 | 13,532,000,000 | 14,248,000,000 | 14,631,000,000 | 7,424,000,000 |
| Last Quarter Net Income | 3,175,360,000 | 4,049,000,000 | -3,369,000,000 | -1,226,000,000 | 8,480,000,000 |
| 60-Month Beta | 0.41 | 0.53 | 0.61 | 0.38 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.71 on 01/31/24 | 2.71 on 04/16/24 | 0.10 on 01/30/24 | 0.03 on 02/01/24 | 1.53 on 01/31/24 |
| Latest Earnings Date | 05/02/24 | 04/16/24 | 05/01/24 | 04/25/24 | 04/23/24 |
| Most Recent Dividend | 0.663 on 03/22/24 | 1.190 on 02/16/24 | 0.420 on 01/25/24 | 0.770 on 03/14/24 | 2.431 on 03/07/24 |
| Next Ex-Dividends Date | 03/22/24 | 05/20/24 | 01/25/24 | 03/14/24 | 03/07/24 |
| Ratios | |||||
| Price/Earnings ttm | 45.80 | 14.15 | 14.16 | 84.13 | 13.86 |